Developments in the management of febrile neutropenia.
作者信息
Pascoe J
出版信息
Br J Cancer. 2011 Aug 23;105(5):597-8. doi: 10.1038/bjc.2011.304.
Abstract
摘要
相似文献
1
Developments in the management of febrile neutropenia.发热性中性粒细胞减少症的管理进展
Br J Cancer. 2011 Aug 23;105(5):597-8. doi: 10.1038/bjc.2011.304.
2
Febrile neutropenia: are you up to date?发热性中性粒细胞减少症：你了解最新情况吗？
Can Oncol Nurs J. 2003 Fall;13(4):246-9.
3
[Consensus on management of children with cancer, neutropenia and fever: Update 2008-2009].[儿童癌症、中性粒细胞减少症和发热管理共识：2008 - 2009年更新]
Arch Argent Pediatr. 2010 Apr;108(2):e47-70. doi: 10.1590/S0325-00752010000200022.
4
Febrile neutropenia.发热性中性粒细胞减少症
BMJ. 2010 Dec 17;341:c6981. doi: 10.1136/bmj.c6981.
5
[Recommendations for Diagnostics and Therapy of Children with Cancer Presenting with Fever and Neutropenia - Comparison of Two Current Guidelines].[癌症患儿发热伴中性粒细胞减少症的诊断与治疗建议——两项现行指南的比较]
Klin Padiatr. 2018 Apr;230(3):115-121. doi: 10.1055/s-0044-101953. Epub 2018 Mar 27.
6
Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia.实体瘤患儿的发热和中性粒细胞减少在严重程度和预后方面与白血病患儿相似。
Support Care Cancer. 2002 Jan;10(1):58-64. doi: 10.1007/s005200100277.
7
[Fever and cancer: components of diagnosis for optimal management].
Rev Med Interne. 2013 Sep;34(9):545-52. doi: 10.1016/j.revmed.2012.10.368. Epub 2012 Nov 27.
8
[Febrile neutropenia at the emergency department of a cancer hospital].[癌症医院急诊科的发热性中性粒细胞减少症]
Rev Med Brux. 2011 Mar-Apr;32(2):74-82.
9
Is it time to redefine the management of febrile neutropenia in cancer patients?是时候重新定义癌症患者发热性中性粒细胞减少症的管理了吗？
Am J Med. 1995 Mar;98(3):221-3. doi: 10.1016/S0002-9343(99)80366-0.
10
Assessing the Impact of ED Triage Directives on Febrile Oncology Patient Wait Times.评估 ED 分诊指令对发热肿瘤患者等待时间的影响。
J Emerg Nurs. 2020 Mar;46(2):254-262.e1. doi: 10.1016/j.jen.2019.12.007.
引用本文的文献
1
The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.发热性中性粒细胞减少症的新模式已经到来：MASCC 评分不足的实际证明。
Clin Transl Oncol. 2017 Sep;19(9):1084-1090. doi: 10.1007/s12094-017-1644-z. Epub 2017 Mar 13.
本文引用的文献
1
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients.疑似稳定的成年癌症患者中性粒细胞减少性发热的预后评估。
Br J Cancer. 2011 Aug 23;105(5):612-7. doi: 10.1038/bjc.2011.284. Epub 2011 Aug 2.
2
Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia.不同儿童发热性中性粒细胞减少症管理策略预期的健康相关生活质量。
Br J Cancer. 2011 Aug 23;105(5):606-11. doi: 10.1038/bjc.2011.213. Epub 2011 Jun 21.
3
Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.成人癌症患者发热性中性粒细胞减少症门诊治疗的成本效益分析。
Br J Cancer. 2011 Apr 26;104(9):1377-83. doi: 10.1038/bjc.2011.101. Epub 2011 Apr 5.
4
Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis.癌症伴发热性中性粒细胞减少症患者的门诊管理：系统评价和荟萃分析。
Ann Oncol. 2011 Nov;22(11):2358-2365. doi: 10.1093/annonc/mdq745. Epub 2011 Mar 1.
5
Management of febrile neutropenia: ESMO Clinical Practice Guidelines.发热性中性粒细胞减少症的管理：ESMO临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v252-6. doi: 10.1093/annonc/mdq196.
6
Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.使用癌症支持治疗多国协会（MASCC）风险指数管理实体瘤和淋巴瘤中的发热性中性粒细胞减少症：常规临床实践中的可行性和安全性
Support Care Cancer. 2008 May;16(5):485-91. doi: 10.1007/s00520-007-0334-8. Epub 2007 Sep 25.
7
Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.使用并发症预测评分对发热性中性粒细胞减少癌症患者进行门诊口服抗生素治疗。
J Clin Oncol. 2006 Sep 1;24(25):4129-34. doi: 10.1200/JCO.2005.03.9909.
8
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.成年癌症患者发热性中性粒细胞减少症相关的死亡率、发病率和成本
Cancer. 2006 May 15;106(10):2258-66. doi: 10.1002/cncr.21847.
9
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.癌症支持治疗多国协会风险指数：一种用于识别低风险发热性中性粒细胞减少癌症患者的多国评分系统。
J Clin Oncol. 2000 Aug;18(16):3038-51. doi: 10.1200/JCO.2000.18.16.3038.
Zotero 插件